Palladium-catalyzed direct alkenylation of 4-hydroxy-2-pyridones

Tania Katsina, Elissavet E. Anagnostaki, Foteini Mitsa, Vasiliki Sarli and Alexandros L. Zografos*
Aristotle University of Thessaloniki, Department of Chemistry, Laboratory of Organic Chemistry, University Campus 54124, Thessaloniki, Greece. E-mail: alzograf@chem.auth.gr

Received 10th December 2015 , Accepted 7th January 2016

First published on 12th January 2016


Abstract

The first direct C-3 alkenylation of N-substituted-4-hydroxy-2-pyridones with unactivated alkenes has been achieved under conventional palladium acetate catalysis. The presented protocol enables the efficient production of functionalized furo[3,2-c]-pyridones-2 when terminal alkenes are utilized and 3-alkenyl-4-hydroxy-2-pyridones when more substituted reaction partners are involved. The mild reaction conditions allow easy, scalable access to pyridone derivatives that resemble core structures isolated from natural alkaloids.


The 4-hydroxy-2-pyridone heteroaromatic core is increasingly attracting the attention of the scientific community due to its abundance in natural alkaloids and its implication in important biological systems.1 Its biological action is mainly dependent on the molecular decoration presented at the 3- and 5-positions of its core. Specific 3-acyl-substituted derivatives were recognized as important neuritogenic compounds targeting the stress pathway kinase MAP4K4.2 On the other hand, selected 3-alkyl derivatives were documented as potent antibacterials3 and antimalarials,4 potentially through their ability to chelate iron.5 Furthermore, bicyclic analogues of 2-pyridones, utilizing the 4-hydroxy-substituent in cycloetheric rings were also found to possess potent antibacterial activities.6 Interestingly, aromatic bicyclic pyridones and especially furo[3,2-c]-pyridones-2 and their 2- and 4-thio-derivatives were utilized as unnatural base pairs for the in vivo expansion of an organism's genetic alphabet and the prophylaxis or the treatment of obesity (Fig. 1).7
image file: c5ra26360c-f1.tif
Fig. 1 Reported direct functionalizations of 4-hydroxy-2-pyridone heteroaromatic core; current work which enables the utilization of unactivated alkenes on the synthesis of diverse pyridone scaffolds and their potential biological utility.

Although pyridone-2 derivatives are increasingly filling the biological active space, still their true biological profile is hampered by the unavailability of simple protocols for their synthesis. The last five years, tremendous efforts have been witnessed in utilizing direct functionalization practices to enrich the synthetic libraries of 2-pyridones and simplify synthetic protocols. Following these efforts, pyridone-2 core and heteroaromatic analogues have been able to be functionalized selectively in 5- and 3-positions by utilizing mainly electrophilic palladation8 or radical initiated SOMO/HOMO interaction9 and in the 6-position by nucleophilic metal addition.10 On the other hand, the literature is particularly poor when describing the direct functionalization of 4-hydroxy-2-pyridones. To the best of our knowledge, only couple of references exist describing their direct 3-alkylation,11 3-arylation12 and very recently their 3-alkenylation with a limited number of activated styrenes13 by utilizing modified palladium-catalyzed Tzuji–Trost, Suzuki and Heck-type reactions respectively (Fig. 1). Surprisingly, none of the reported direct alkenylation methods either on the 4-hydroxy-2-pyridone,13b analogous heteroaromatics13a or pyridone-2 rings8a have manage to utilize an unactivated alkene as reaction partner of the requisite Heck reaction, precluding the utilization of such methods on the preparation of useful alkylated substrates as those shown in Fig. 1.

Recently, we were involved into the synthesis of 4-hydroxy-2-pyridone alkaloids14 and during this endeavour we discovered that we were able to selectively direct metalate the 3-position of N-alkylated-4-hydroxy-2-pyridone moiety, even at ambient temperature with the aid of palladium acetate.12

Based on this success, we challenged ourselves whether it would be possible to target directly the underexplored alkylated 4-hydroxy-2-pyridone derivatives, especially those resembling our previously discovered common synthetic intermediate 2 for the synthesis of citridone and septoriamycin A antibacterials15 or the biological intriguing bicyclic compounds 1 (Fig. 1).

In order to test this working hypothesis, a palladium-catalyzed direct Heck type reaction of 4-hydroxy-2-pyridone ring with unactivated alkenes was envisioned.16 N-Methyl-4-hydroxy-2-pyridone (3) and 1-hexene (4) were chosen as starting materials for this survey. In our first attempts, when 3 was allowed to react with 4 in DMF at 90 °C, in the presence of palladium acetate, mixtures of 3-alkylated products were isolated along with unreacted pyridone 3. Purification and characterization of the reaction mixture revealed not the expected simply 3-alkylated product but instead the coupled products 5–6 along with high ratio of the previously described methyl-dipyridone (7)12 (Table 1).

Table 1 Palladium-catalyzed reaction of N-methyl-4-hydroxy-2-pyridone and unactivated-alkene, hexene-1: optimization of reaction parametersa

image file: c5ra26360c-u1.tif

Entry Catalyst (10 mol%) Solvent Conversion (%) Combined yield (%) Ratiob 5[thin space (1/6-em)]:[thin space (1/6-em)]6[thin space (1/6-em)]:[thin space (1/6-em)]7
a Reaction conditions: 3 (0.08 mmol), 4 (0.32 mmol), solvent (1 mL), catalyst (10 mmol%), Cu(OAc)2 (0.16 mmol), 90 °C, 12 h.b Ratio was determined by 1H NMR spectroscopy.c Benzoquinone (2 equiv.) was used as oxidant.d Silver carbonate (0.08 mmol) was used as an additive.
1 Pd(OAc)2 DMF 76 66 0.6[thin space (1/6-em)]:[thin space (1/6-em)]0.1[thin space (1/6-em)]:[thin space (1/6-em)]1
2 Pd(OAc)2 Dioxane 73 68 3[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]1
3 Pd(OAc)2 CH3CN 80 76 2[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]1
4 Pd(OAc)2 AcOEt 50 42 2[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]1
5 Pd(OAc)2 Toluene 0 NR
6 CH3CN 0 NR
7 Pd(OAc)2c CH3CN 10 8 2[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]1
8 FeCl3 Dioxane 0 NR
9 CuI DMF 0 NR
10 PdCl2 CH3CN 71 69 1[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]1
11 PdCl2d CH3CN 60 57 0.5[thin space (1/6-em)]:[thin space (1/6-em)]0[thin space (1/6-em)]:[thin space (1/6-em)]1
12 Pd(PPh3)4 CH3CN 0 NR


The ratio of these products was highly dependent on the polarity of the solvent as evidenced by their yields when the reaction was screened in a window from DMF to toluene. The reaction remained sluggish in all attempts providing high yields of unreacted starting materials, even at long reaction times (20–100% for 12 h reaction; Table 1). More polar solvents promote the coupling reaction (DMF vs. toluene entries 1 and 5; Table 1), but produce higher ratio of dipyridone byproduct, compared to less polar solvents, something that was also observed in the arylation of 4-hydroxy-2-pyridones.12

Acetonitrile was recognized as the solvent of choice not only by producing the lowest yields of unreacted starting pyridone 3 but also by minimizing the ratio of the produced isomeric compound 6 (entry 3; Table 1). Interestingly dioxane produce an inverse ratio of the two alkylated products changing the 5[thin space (1/6-em)]:[thin space (1/6-em)]6 = 40[thin space (1/6-em)]:[thin space (1/6-em)]20 acetonitrile ratio to 5[thin space (1/6-em)]:[thin space (1/6-em)]6 = 26[thin space (1/6-em)]:[thin space (1/6-em)]39 (entries 2 and 3; Table 1). Entries 6, 8 and 9 support that the reaction proceeds only with the aid of a palladium complex as catalyst, except in cases where styrene is used as coupling partner, where FeCl3 was found to be an efficient radical activator,17 something that additionally corroborates for the effectiveness of styrenes as reaction substrates. Finally, palladium acetate is superior to other palladium catalytic systems as PdCl2, PdCl2/Ag2CO3 and Pd(PPh3)4 (entries 10–12; Table 1).

Trying to explain the persistent production of the isomeric compound 6 in the reaction mixture, we attributed part of its formation on the prior isomerization of the terminal alkene in the presence of palladium catalysis. Literature survey suggests that these isomeric mixtures can be attributed to palladium cationic intermediates.18 Having this in mind, we wanted to evaluate the reaction profile when basic or acidic additives are utilized (Table 2).

Table 2 Involvement of basic and acidic conditions on palladium catalyzed reaction of N-methyl-4-hydroxy-2-pyridones with hexene-1a

image file: c5ra26360c-u2.tif

Entry Additive Solvent Temp (°C) Time (h) Conv (%) Yieldsb (%) 5[thin space (1/6-em)]:[thin space (1/6-em)]6[thin space (1/6-em)]:[thin space (1/6-em)]7
a Reaction conditions: 3 (0.24 mmol), 4 (0.72 mmol), solvent (3 mL), catalyst (5 mmol%), Cu(OAc)2 (0.24 mmol), additive (0.48 mmol), at indicative temperature and time.b Yields correspond to isolated compounds.
1 Et3N CH3CN 90 12
2 K2CO3 CH3CN 90 12 62 25[thin space (1/6-em)]:[thin space (1/6-em)]5[thin space (1/6-em)]:[thin space (1/6-em)]32
3 NaHCO3 CH3CN 90 12 72 45[thin space (1/6-em)]:[thin space (1/6-em)]9[thin space (1/6-em)]:[thin space (1/6-em)]18
4 K2CO3 CH3CN 60 12 64 20[thin space (1/6-em)]:[thin space (1/6-em)]0[thin space (1/6-em)]:[thin space (1/6-em)]44
5 K2CO3 CH3CN 25 24 40 10[thin space (1/6-em)]:[thin space (1/6-em)]0[thin space (1/6-em)]:[thin space (1/6-em)]30
6 K2CO3 Dioxane 60 12 68 17[thin space (1/6-em)]:[thin space (1/6-em)]17[thin space (1/6-em)]:[thin space (1/6-em)]34
7 CH3COOH None 90 4 100 71[thin space (1/6-em)]:[thin space (1/6-em)]29[thin space (1/6-em)]:[thin space (1/6-em)]0
8 CH3COOH CH3CN 90 4 100 59[thin space (1/6-em)]:[thin space (1/6-em)]38[thin space (1/6-em)]:[thin space (1/6-em)]0
9 PivOH CH3CN 90 4 100 48[thin space (1/6-em)]:[thin space (1/6-em)]40[thin space (1/6-em)]:[thin space (1/6-em)]12
10 HCOOH CH3CN 90 4 100 76[thin space (1/6-em)]:[thin space (1/6-em)]10[thin space (1/6-em)]:[thin space (1/6-em)]0
11 HCOOH Dioxane 90 4 100 36[thin space (1/6-em)]:[thin space (1/6-em)]63[thin space (1/6-em)]:[thin space (1/6-em)]0
12 HCOOH CH3CN 60 3 100 82[thin space (1/6-em)]:[thin space (1/6-em)]0[thin space (1/6-em)]:[thin space (1/6-em)]0
13 HCOOH CH3CN 40 3 100 80[thin space (1/6-em)]:[thin space (1/6-em)]0[thin space (1/6-em)]:[thin space (1/6-em)]0
14 HCOOH Dioxane 40 3 100 59[thin space (1/6-em)]:[thin space (1/6-em)]41[thin space (1/6-em)]:[thin space (1/6-em)]0


Addition of a base accelerates the reaction that now proceeds at lower temperature but still without driving it to completion (entries 1–6; Table 2). Unfortunately, although the use of basic conditions minimizes isomeric product 6, it enhances the production of dipyridone 7. Potassium carbonate is superior to other bases, with Et3N being the worse producing undefined mixture of products (entry 1; Table 2).

On the other hand, utilization of acidic conditions accelerate the reaction to completion, even at low temperatures (entry 7–14; Table 2) and provides a simpler reaction mixture profile as observed by 1H NMR spectroscopy. Acidic conditions prohibited the formation of dipyridone 7, while minimized the production of isomer 6, majorly due to the milder reaction conditions that can be employed (Table 2). Formic acid leads to minimization of isomer 6 (with the exception of dioxane) compared to other acids, like acetic and pivalic acid. It has to be pointed out that higher temperature and prolonged reaction times, still with the aid of formic acid, can produce low yields of the isomer 6. Based on these results, optimized reaction conditions include the utilization of CH3CN as the solvent, with acidic conditions provided by 2 equiv. of formic acid, at 40 °C. Commonly, depending on the alkene substrate (Scheme 2), the reaction does not require more than 3 h at 40 °C to be completed.

Preliminary studies on the reaction mechanism suggests a catalytic cycle that starts with the direct activation of 4-hydroxy-2-pyridone by Pd(II) (Scheme 1).19 Migratory insertion of pyridone-palladium species 8 to alkenes, followed by reductive elimination produces products 10 or 11 after further oxidation, depending on the substrate and releases Pd(0). Pd(0) is re-entered the catalytic cycle after its oxidation by copper acetate (Scheme 1).


image file: c5ra26360c-s1.tif
Scheme 1 Postulated reaction mechanism.

Apart from the main catalytic pathway, anion of 4-hydroxy-2-pyridone (12), formed under basic conditions, becomes a competing substrate to alkene for palladium species 8 to produce dipyridone (13). On the other hand, the formation of the observed isomeric compound 16 is much less obvious and can be attributed potentially either to the direct isomerization of the starting terminal alkene under the applied reaction conditions and its later reaction with complex 8 or due to the poor regioselectivity of the migratory insertion of palladium-complex 8 directly to the alkene (intermediate 9), isomerization of the resulting 14 and further elaboration to the final products 15 and 16. Interestingly, such alkenes isomerizations are known to be enhanced in the presence of free phenols something that corroborates to the validity of the later pathway.20

Wishing to investigate further these pathways, we checked the ability of 1-hexene to isomerize independently by palladium, omitting the use of 4-hydroxy-2-pyridone in reaction conditions. Interestingly, 1-hexene produces its isomer, 2-hexene in 5–10% yield when is heated in dioxane overnight at high temperatures (100–120 °C). No evidence of such isomerization has been witnessed at lower temperatures and shorter reaction times. This of course does not exclude isomerization of the alkene from complex 8, but so far no evidence of even traces of isomerized alkene have been identified by GC. What is more, utilization of similar compounds to the potential isomerized alkene, like 2-pentene, as reaction partners did not provide the furo-cyclized product 16 or the regioisomeric compound 15 but rather leads to a regioselective addition to form compound 17 (Scheme 2). Inductively, the latter suggests the direct dependence of regioselectivity of migratory insertion of intermediate 9 on the reaction outcome, which is diverted in the cases of acetonitrile and dioxane media. Several studies, related to the Heck reaction, correlate the regioselectivities observed on the insertion of terminal electron rich alkenes to the nature of the palladium species applied in the Heck reaction.21 Based on these studies, our case, as indicated from the regioselectivities presented above, indicates a neutral-type mechanism in acetonitrile which changes to cationic when reaction is conducted in dioxane.21 Although this interesting behavior is important and it seeks of further investigation it does not meet the purpose of the current study.


image file: c5ra26360c-s2.tif
Scheme 2 Substrate scope and a potential mechanism for the formation of compound 25.

Having in our hands the optimized protocol for the alkenylation of 4-hydroxy-2-pyridones, we seeked to explore its ability on different substrates including terminal and internal alkenes but also activated partners as styrenes and acrylates (Scheme 2). As shown in Scheme 2, N-substituted 4-hydroxy-2-pyridones were able to react under the optimized reaction conditions with electron rich and electron deficient alkenes providing moderate to excellent yields on the final products (57–96%) by applying low temperature and short reaction times (2.5–4.5 h). Electron rich, unactivated, terminal alkenes are providing the lowest yields compared to styrene and acrylates. On the contrary, the utilization of unactivated, internal alkenes produce 3-alkylated products in moderate yields which do not proceed further to elaborate etherocyclization or furan formation. The latter is potentially attributed to the high sterics invoked in the transition state of the final cyclization step. This was further supported by the reaction of 2,2-disubstituted alkenes to produce also uncyclized 3-alkylated products due to sterics (compound 25 from β-pinene).

Interestingly, in all cases, cyclized and non-cyclized, the regioisomeric product has not been observed in higher than 10% yield. What is more, an unproblematic scale-up was feasible under the optimized reaction conditions. Thus, when 2 mmol of N-methyl-4-hydroxy-2-pyridone and styrene were reacted a similar yield of compound 19 was isolated (90%), even at lower loadings of palladium acetate catalyst (2%).

In conclusion, the first direct 3-alkenylation of N-substituted 4-hydroxy-2-pyridones with unactivated alkenes is reported through a palladium acetate catalyzed, oxidative coupling. Compared to the other alkenylation methods, our protocol enables the utilization of both activated and unactivated alkenes as reaction partners. It solves the highly challenging issue of migratory regioselectivity allowing an easy and scalable access to highly functionalized 4-hydroxy-2-pyridones that can be readily used to access an array of biological intriguing compounds.

Notes and references

  1. H. J. Jessen and K. Gademann, Nat. Prod. Rep., 2010, 27, 1168 RSC.
  2. (a) P. Schöder, T. Förster, S. Kleine, C. Becker, A. Richters, S. Ziegler, D. Rauh, K. Kumar and H. Waldmann, Angew. Chem., Int. Ed., 2015, 54, 12398 CrossRef PubMed; (b) K. Schmidt, W. Günther, S. Stoyanova, B. Schubert, Z. Li and M. Hamburger, Org. Lett., 2002, 4, 197 CrossRef CAS PubMed.
  3. M. M. Wagenaar, D. M. Gibson and J. Clardy, Org. Lett., 2002, 4, 671 CrossRef CAS PubMed.
  4. M. Isaka and M. Tanticharoen, J. Org. Chem., 2001, 66, 4803 CrossRef CAS PubMed.
  5. A. Jegorov, V. Matha, M. Husak, B. Kratochvil, J. Stuchilik, P. Sedmera and V. Havlicek, J. Chem. Soc., Dalton Trans., 1993, 1287 RSC.
  6. (a) M. R. TePaske, J. B. Gloer, D. T. Wicklow and P. F. Dowd, Tetrahedron Lett., 1991, 32, 5687 CrossRef CAS; (b) B. B. Snider and Q. Lu, Synth. Commun., 2001, 31, 2667 CrossRef CAS; (c) T. Fukuda, H. Tomoda and S. Omura, J. Antibiot., 2005, 58, 315 CrossRef CAS PubMed.
  7. For their use as unnatural base pairs please refer to: (a) A. A. Henry, C. Yu and F. E. Romesberg, J. Am. Chem. Soc., 2003, 125, 9638 CrossRef CAS PubMed; (b) L. Li, M. Degardin, T. Lavergne, D. A. Malyshev, K. Dhami, P. Ordoukhanian and F. E. Romesberg, J. Am. Chem. Soc., 2014, 136, 826 CrossRef CAS PubMed . For prophylaxis from obesity please refer to patents: WO 2013/168760 and EP 2 848 622 A1 from Takeda Pharmaceutical Company Limited.
  8. (a) Y. Chen, F. Wang, A. Jia and X. Li, Chem. Sci., 2012, 3, 3231 RSC; (b) D. Cheng and T. Gallagher, Org. Lett., 2009, 11, 2639 CrossRef CAS PubMed; (c) V. Ortiz-de-Elguea, N. Sotomayor and E. Lette, Adv. Synth. Catal., 2015, 357, 463 CrossRef CAS.
  9. (a) A. Nakatani, K. Hirano, T. Satoh and M. Miura, Chem.–Eur. J., 2013, 19, 7691 CrossRef CAS PubMed; (b) A. Modak, S. Rana and D. Maiti, J. Org. Chem., 2015, 80, 296 CrossRef CAS PubMed; (c) A. Nakatani, K. Hirano, T. Satoh and M. Miura, J. Org. Chem., 2014, 79, 1377 CrossRef CAS PubMed.
  10. (a) R. Tamura, Y. Yamada, Y. Nakao and T. Hiyama, Angew. Chem., Int. Ed., 2012, 51, 5679 CrossRef CAS PubMed; (b) Y. Nakao, H. Idei, K. S. Kanyiva and T. Hiyama, J. Am. Chem. Soc., 2009, 131, 15996 CrossRef CAS PubMed; (c) R. Odani, K. Hirano, T. Satoh and M. Miura, Angew. Chem., Int. Ed., 2014, 53, 10784 CrossRef CAS PubMed; (d) P. A. Donets and N. Cramer, Angew. Chem., Int. Ed., 2015, 54, 633 CAS; (e) J. G. Sośnicki, P. Dzitkowski and L. Struk, Eur. J. Org. Chem., 2015, 5089 Search PubMed.
  11. (a) A. Fürstner, F. Feyen, H. Prinz and H. Waldmann, Angew. Chem., Int. Ed., 2003, 42, 5361 CrossRef PubMed; (b) A. Fürstner, F. Feyen, H. Prinz and H. Waldmann, Tetrahedron, 2004, 9543 CrossRef.
  12. (a) E. E. Anagnostaki, V. P. Demertzidou and A. L. Zografos, Chem. Commun., 2014, 50, 6879 RSC; (b) L. M. Pardo, A. M. Prendergast, M.-T. Nolan, E. O. Muinhneachain and G. P. McGlacken, Eur. J. Org. Chem., 2015, 3540 CrossRef CAS.
  13. (a) Similar protocols utilized coumarin heteroaromatic core by X.-c. Tan, H.-y. Zhao, Y.-m. Pan, N. Wu, H.-s. Wang and Z.-f. Chen, RSC Adv., 2015, 5, 4972 RSC and ; (b) its expansion in pyrones and 4-hydroxy-2-pyridones by H. U. Lah, F. Rasool and S. K. Yousuf, RCS Adv., 2015, 5, 78958 CAS came to our attention during the preparation of our manuscript, describing the 3-alkenylation of heteroaromatics by activated styrene derivatives.
  14. (a) A. D. Fotiadou and A. L. Zografos, Org. Lett., 2011, 13, 4592 CrossRef CAS PubMed; (b) A. D. Fotiadou and A. L. Zografos, Org. Lett., 2012, 14, 5664 CrossRef CAS PubMed.
  15. E. E. Anagnostaki and A. L. Zografos, Chem. Soc. Rev., 2012, 41, 5613 RSC.
  16. J. Le Bras and J. Muzart, Chem. Rev., 2011, 111, 1170 CrossRef CAS PubMed ; for selected direct dehydrogenative Heck reactions with unactivated alkenes please see: Z. Wang, B. J. Reinus and G. Dong, J. Am. Chem. Soc., 2012, 134, 13954 CrossRef PubMed; A. Deb, S. Bag, R. Kancherla and D. Maiti, J. Am. Chem. Soc., 2014, 136, 13602 CrossRef PubMed; S. Yu, S. Liu, Y. Lan, B. Wan and X. Li, J. Am. Chem. Soc., 2015, 137, 1623 CrossRef PubMed.
  17. Preliminary results show that Fe(iii) are efficient catalysts for the 3-selective alkenylation of 4-hydroxy-2-pyridones with styrene derivatives. Studies are under way and will be communicated elsewhere.
  18. (a) A. Sen and T.-W. Lai, Inorg. Chem., 1981, 20, 4036 CrossRef CAS; (b) A. Sen and T.-W. Lai, Inorg. Chem., 1984, 23, 3257 CrossRef CAS.
  19. Please refer to the ESI† of ref. 12 for spectroscopic studies.
  20. J. Fan, C. Wan, Q. Wang, L. Gao, Z. Zheng and Z. Wang, Org. Biomol. Chem., 2009, 7, 3168 Search PubMed ; for selected related couplings with phenols please see: U. Sharma, T. Naveen, A. Maji, S. Manna and D. Maiti, Angew. Chem., Int. Ed., 2013, 52, 12669 CrossRef CAS PubMed; S. Agasti, S. Maiti, K. J. Szabo and D. Maiti, Adv. Synth. Catal., 2015, 357, 2331 CrossRef PubMed.
  21. (a) The Mizoroki–Heck Reaction, ed. M. Oestreich, Wiley, 2009 Search PubMed; (b) P. Fristup, S. Le Quement, D. Tanner and P.-O. Norrby, Organometallics, 2004, 23, 6160 CrossRef; (c) P. Wucher, L. Caporaso, P. Roesle, F. Ragone, L. Cavallo, S. Macking and I. Göttker-Schnetmann, Proc. Natl. Acad. Sci. U. S. A., 2011, 108, 8955 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Characterization data, experimental procedures and copies of spectra. See DOI: 10.1039/c5ra26360c

This journal is © The Royal Society of Chemistry 2016
Click here to see how this site uses Cookies. View our privacy policy here.